echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Lancet Psychiatry: The latest study found that more than one-third of patients with new crowns have brain problems

    Lancet Psychiatry: The latest study found that more than one-third of patients with new crowns have brain problems

    • Last Update: 2021-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 6, US Eastern time, the Lancet magazine "The Lancet Psychiatry" (The Lancet Psychiatry) recently published the largest study to date.


    More than one-third of COVID-19 cured patients have brain problems and are diagnosed with neurological or mental illness within six months of the infection.


    This retrospective study, funded by the National Institutes of Health (NIHR) Oxford Health Biomedical Research Center, analyzed 236,379 COVID-19 patients in the United States (over 10 years old, infected on and after January 20, 2020, December 13, 2020).


    Researchers found that as many as 33.


    Among them, 17% of patients were diagnosed with anxiety, and 14% of patients suffered from mood disorders.


    The researchers also said that if the statistics included inpatients, the proportion of patients with brain problems would rise to 39%.


    In addition, the research team also compared the data of 1,05579 patients diagnosed with influenza and 236,038 patients diagnosed with any respiratory infections (including influenza) during the same period.


    Taking into account basic health characteristics such as age, gender, ethnicity, and underlying diseases, the risk of neurological and mental illness diagnosed in patients with new crown infection is 44% higher than that of influenza patients and 16% higher than that of patients with respiratory tract infections.


    This means that compared with other influenza and respiratory diseases, the new crown infection does bring a higher risk of neurological and mental diseases.


    The research team also admits that the research has limitations.


    "This is real-world data collected from a large number of patients.


    Original source:

    Original source:

    Maxime Taquet, et al.


    6-month neurological and psychiatric outcomes in 236?379 survivors of COVID-19: a retrospective cohort study using electronic health records.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.